Violations of Vietnamese laws related to the online marketing of breastmilk substitutes: Detections using a virtual violations detector
Maternal & Child Nutrition · 2025
DOI: 10.1111/mcn.13680 ↗At a glance
Journal article in Maternal & Child Nutrition, 2025. Written by Kathryn Backholer and 5 co-authors. Institution: Geelong, Global Centre for Preventive Health and Nutrition, Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia. Major MEDLINE topics: Marketing. Cited 11 times so far (Crossref); 12 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Bill and Melinda Gates Foundation, Australian Research Council.
Abstract (original language)
Breastfeeding rates in Vietnam, and globally, remain suboptimal. A major contributor to this is the aggressive marketing of commercial milk formulas (CMF), mainly through online media. The Vietnamese Government has implemented legal measures to limit CMF marketing, but these have been difficult to enforce, because of complex online environments. We aimed to quantify the extent and nature of online violations and contradictions in various Vietnamese laws related CMF marketing over 12 months in 2022. Using a cross‐sectional study design, we used an artificial intelligence‐enabled virtual violations detector (VIVID) to monitor official websites and social media pages of 25 breastmilk substitute (BMS) merchandise and distributors, every day for 12 months in 2022. Data were summarised descriptively. We detected more than 3000 online advertisements that violated or contradicted the intent of Vietnamese laws, involving almost 7000 violations of various articles within these laws (average 9.5 violations per day). More than 700 detections were related to CMF products being registered as “supplementary foods” or similar, thereby circumventing Vietnamese CMF marketing laws, because they are not registered as “BMS products. We demonstrate the need to strengthen the design, monitoring and enforcement of existing Vietnamese laws to eliminate mothers” exposure to the exploitative digital marketing of CMF. By turning a highly resource‐intensive task into one that is, automated requiring substantially less resources, our study represents the most comprehensive in Vietnam and internationally on the extent and nature of the online marketing of BMS. VIVID can be applied worldwide to hold industry accountable for the inappropriate marketing of CMF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Geelong, Global Centre for Preventive Health and Nutrition, Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia.
- Alive & Thrive, Global Nutrition, Hanoi, Vietnam.
- Alive & Thrive, Global Nutrition, Washington, District of Columbia, USA.
- Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
ORCID profiles: Kathryn Backholer, Constance Ching, Phil Baker, Roger Mathisen
Funding
- Wellcome Trust
- Bill and Melinda Gates Foundation
- Australian Research Council
- National Heart Foundation of Australia
Cite
APA
Backholer, K., Nguyen, L., Vu, D., Ching, C., Baker, P., & Mathisen, R. (2025). Violations of Vietnamese laws related to the online marketing of breastmilk substitutes: Detections using a virtual violations detector. Maternal & Child Nutrition. https://doi.org/10.1111/mcn.13680
Vancouver
Backholer K, Nguyen L, Vu D, Ching C, Baker P, Mathisen R. Violations of Vietnamese laws related to the online marketing of breastmilk substitutes: Detections using a virtual violations detector. Maternal & Child Nutrition. 2025. doi:10.1111/mcn.13680
BibTeX
@article{Backholer2025,
author = {Backholer, Kathryn and Nguyen, Linh and Vu, Duong and Ching, Constance and Baker, Phil and Mathisen, Roger},
title = {Violations of Vietnamese laws related to the online marketing of breastmilk substitutes: Detections using a virtual violations detector},
journal = {Maternal & Child Nutrition},
year = {2025},
doi = {10.1111/mcn.13680}
}
EUVIMED